SEC Form 4 · accession 0001209191-15-079318
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herb Cross
Officer — Chief Financial Officer
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.95 | Nov 9, 2015 | A | 1,875 | A | Nov 9, 2016 | Nov 8, 2025 | Common Stock | 1,875 | 1,875 | D |
Explanation of responses
- F1The option shares will vest and become exercisable ratably over 12 months of continuous service beginning on November 9, 2015, subject to the terms of the Company's 2012 Equity Incentive Plan.